Literature DB >> 20799324

A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Goutières syndrome.

Charlotte A Haaxma1, Yanick J Crow, Maurice A M van Steensel, Martin M Y Lammens, Gillian I Rice, Marcel M Verbeek, Michèl A A P Willemsen.   

Abstract

Aicardi-Goutières syndrome is a rare, genetically determined encephalopathy often resembling congenital infection. Mutations in the TREX1 gene are found in approximately 25% of patients. Aicardi-Goutières syndrome is usually inherited as an autosomal recessive trait, although a single case of a heterozygous TREX1 mutation associated with the syndrome has been reported. We present a second case of a de novo heterozygous TREX1 mutation causing an autosomal dominant phenotype of Aicardi-Goutières syndrome with additional features indicative of mitochondrial dysfunction. This report serves to enhance awareness of de novo heterozygous mutations underlying Aicardi-Goutières syndrome-with a concomitant low risk of recurrence.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20799324     DOI: 10.1002/ajmg.a.33620

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  12 in total

1.  The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity.

Authors:  Clinton D Orebaugh; Jason M Fye; Scott Harvey; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

Review 2.  Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies.

Authors:  Maroof Hasan; Nan Yan
Journal:  Pharmacol Res       Date:  2016-06-25       Impact factor: 7.658

3.  TREX1 D18N mice fail to process erythroblast DNA resulting in inflammation and dysfunctional erythropoiesis.

Authors:  Stephen L Rego; Scott Harvey; Sean R Simpson; Wayne O Hemphill; Zachariah A McIver; Jason M Grayson; Fred W Perrino
Journal:  Autoimmunity       Date:  2018-11-13       Impact factor: 2.815

4.  Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome.

Authors:  Jason M Fye; Clinton D Orebaugh; Stephanie R Coffin; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2011-08-01       Impact factor: 5.157

Review 5.  Human disease phenotypes associated with mutations in TREX1.

Authors:  Gillian I Rice; Mathieu P Rodero; Yanick J Crow
Journal:  J Clin Immunol       Date:  2015-03-04       Impact factor: 8.317

6.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.

Authors:  Gillian I Rice; Paul R Kasher; Gabriella M A Forte; Niamh M Mannion; Sam M Greenwood; Marcin Szynkiewicz; Jonathan E Dickerson; Sanjeev S Bhaskar; Massimiliano Zampini; Tracy A Briggs; Emma M Jenkinson; Carlos A Bacino; Roberta Battini; Enrico Bertini; Paul A Brogan; Louise A Brueton; Marialuisa Carpanelli; Corinne De Laet; Pascale de Lonlay; Mireia del Toro; Isabelle Desguerre; Elisa Fazzi; Angels Garcia-Cazorla; Arvid Heiberg; Masakazu Kawaguchi; Ram Kumar; Jean-Pierre S-M Lin; Charles M Lourenco; Alison M Male; Wilson Marques; Cyril Mignot; Ivana Olivieri; Simona Orcesi; Prab Prabhakar; Magnhild Rasmussen; Robert A Robinson; Flore Rozenberg; Johanna L Schmidt; Katharina Steindl; Tiong Y Tan; William G van der Merwe; Adeline Vanderver; Grace Vassallo; Emma L Wakeling; Evangeline Wassmer; Elizabeth Whittaker; John H Livingston; Pierre Lebon; Tamio Suzuki; Paul J McLaughlin; Liam P Keegan; Mary A O'Connell; Simon C Lovell; Yanick J Crow
Journal:  Nat Genet       Date:  2012-09-23       Impact factor: 38.330

Review 7.  Therapies in Aicardi-Goutières syndrome.

Authors:  Y J Crow; A Vanderver; S Orcesi; T W Kuijpers; G I Rice
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

8.  TREX-1-Related Disease Associated with the Presence of Cryofibrinogenemia.

Authors:  C Paradis; M Cadieux-Dion; C Meloche; M Gravel; J Paradis; A Des Roches; G Leclerc; P Cossette; P Begin
Journal:  J Clin Immunol       Date:  2019-01-26       Impact factor: 8.317

Review 9.  Aicardi-Goutières syndrome: a model disease for systemic autoimmunity.

Authors:  M A Lee-Kirsch; C Wolf; C Günther
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

10.  How an exonuclease decides where to stop in trimming of nucleic acids: crystal structures of RNase T-product complexes.

Authors:  Yu-Yuan Hsiao; Yulander Duh; Yi-Ping Chen; Yi-Ting Wang; Hanna S Yuan
Journal:  Nucleic Acids Res       Date:  2012-06-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.